12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Tuesday's intraday session, with notable gainers including Janux Therapeutics, Viking Therapeutics, and CytomX Therapeutics, among others. Losers for the day included Minerva Neurosciences, NRX Pharmaceuticals, and Calidi Biotherapeutics. Factors influencing these movements include recent earnings reports for some companies.
February 27, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hims & Hers Health shares increased by 31.02% to $13.43, with a market cap of $2.8 billion, following its Q4 earnings report.
The positive response to Hims & Hers Health's Q4 earnings report indicates strong performance, likely leading to further short-term stock appreciation.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Janux Therapeutics stock surged 189.9% to $43.78, with a market cap of $2.0 billion.
The significant surge in Janux Therapeutics' stock price could attract more investors, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Viking Therapeutics shares increased by 91.96% to $73.87, with a market cap of $7.4 billion.
Viking Therapeutics' substantial price increase could lead to heightened investor interest, potentially driving the stock higher in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Minerva Neurosciences stock fell 57.1% to $2.92, with a market cap of $20.4 million, following its Q4 earnings report.
The sharp decline in Minerva Neurosciences' stock price post-earnings suggests a negative market reaction, likely leading to further short-term downside.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100